Cargando…

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports

This is the first case report on two children presenting with immediate and severe hemolytic anemia following the administration of high-dose intravenous immunoglobulins (IVIGs) in the context of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). Hemolytic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlin, E., Lau, S., von Bernuth, H., Kallinich, T., Mayer, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126396/ https://www.ncbi.nlm.nih.gov/pubmed/37114004 http://dx.doi.org/10.3389/fped.2023.1144914

Ejemplares similares

Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial
por: Welzel, Tatjana, et al.
Publicado: (2022)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
por: Okulu, Emel, et al.
Publicado: (2022)

Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS—results from a single centre study in the UK
por: Jiju, Prince, et al.
Publicado: (2023)

Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
por: Chan, Jaclyn
Publicado: (2023)

An adult presentation consistent with PIMS-TS
por: Jones, Imogen, et al.
Publicado: (2020)

Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
por: Schlapbach, Luregn J., et al.
Publicado: (2021)

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
por: Berard, Roberta, et al.
Publicado: (2012)

Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany
por: Wehl, Götz, et al.
Publicado: (2021)

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial
por: Welzel, Tatjana, et al.
Publicado: (2023)

Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization
por: Acosta, Catalina, et al.
Publicado: (2021)

Case report: Microangiopathic hemolytic anemia and thrombocytopenia in a child with Brucella infection
por: Alkhunein, Atheer, et al.
Publicado: (2023)

Rapidly Progressing Autoimmune Hemolytic Anemia in a Pediatric Patient With COVID-19
por: Kononowicz, Julia E, et al.
Publicado: (2023)

Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia
por: Tripodi, Serena I., et al.
Publicado: (2018)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
por: Genu, Daniel Hilário Santos, et al.
Publicado: (2022)

Viral infections in hospitalized children in Germany during the COVID-19 pandemic: Association with non-pharmaceutical interventions
por: Terliesner, Nicolas, et al.
Publicado: (2022)

Risk of paediatric multisystem inflammatory syndrome (PIMS-TS) during the SARS-CoV-2 alpha and delta variant waves: National observational and modelling study, 2020–21, England
por: Shingleton, Joseph, et al.
Publicado: (2022)

COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)
por: Musilová, Tereza, et al.
Publicado: (2023)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
por: Kuniyoshi, Yasutaka, et al.
Publicado: (2020)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment
por: Mastrolia, Maria Vincenza, et al.
Publicado: (2021)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Can PIMS-TS lead to a facial nerve palsy?
por: Hookham, Lauren, et al.
Publicado: (2021)

Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children
por: Riphagen, Shelley
Publicado: (2020)

Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies
por: Liu, Gengying, et al.
Publicado: (2020)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
por: Choi, In Su, et al.
Publicado: (2022)

Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation—etiological and therapeutic issues
por: Turudic, Daniel, et al.
Publicado: (2023)

Streptococcus pneumoniae associated hemolytic uremic syndrome in children
por: Young, Heather L., et al.
Publicado: (2023)

Type O blood, the MCHC, and the reticulocyte count impact the early recurrence of primary warm-antibody autoimmune hemolytic anemia in children: A retrospective cohort analysis
por: Li, Jiacheng, et al.
Publicado: (2022)

Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany
por: Sorg, Anna-Lisa, et al.
Publicado: (2022)

Early recognition of PIMS-TS: a single centre retrospective review
por: Mistry, Roshni, et al.
Publicado: (2021)

COVID-19 and the paediatric acute abdomen—the emerging dilemma of PIMS-TS
por: Walker, Eleanor T., et al.
Publicado: (2022)

Acute Vision Loss and Conjunctival Hemorrhage as Telltale Symptoms of PIMS-TS
por: Nassih, Houda, et al.
Publicado: (2022)

Neuro-PIMS-TS: a single case report and review of the literature
por: Scarcella, Antonio, et al.
Publicado: (2022)

Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

PIMS-TS vs. MIS-C: Diagnostic Criteria in COVID-19–Associated Hyperinflammation in Children
por: Sarkar, Mihir, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation in children with COVID-19 and PIMS-TS during the second and third wave
por: Di Nardo, Matteo, et al.
Publicado: (2022)

Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
por: Ranabothu, Saritha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pbjh4itolp8og5bcur3gultp4j